Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 113

1.

Characterization and Inception of a Triterpenoid Astrakurkurol, as a Cytotoxic Molecule on Human Hepatocellular Carcinoma Cells, Hep3B.

Nandi S, Chandra S, Sikder R, Bhattacharya S, Ahir M, Biswal D, Adhikary A, Pramanik NR, Lai TK, Drew MGB, Acharya K.

J Agric Food Chem. 2019 Jul 10;67(27):7660-7673. doi: 10.1021/acs.jafc.9b01203. Epub 2019 Jun 28.

PMID:
31250646
2.

Association of p38MAPK-p53-Fas aggregation in S-allyl cysteine mediated regulation of hepatocarcinoma.

Chatterjee S, Patra D, Chakraborti U, Sengupta D, Ghosh P, Basu A, Sadhukhan GC, Chowdhury KD.

Environ Toxicol. 2019 Aug;34(8):928-940. doi: 10.1002/tox.22764. Epub 2019 May 8.

PMID:
31067004
3.

STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells.

Guha P, Gardell J, Darpolor J, Cunetta M, Lima M, Miller G, Espat NJ, Junghans RP, Katz SC.

Oncogene. 2019 Jan;38(4):533-548. doi: 10.1038/s41388-018-0449-z. Epub 2018 Aug 29.

PMID:
30158673
4.

Stress of Strains: Inbred Mice in Liver Research.

Rogers AB.

Gene Expr. 2018 Dec 14;19(1):61-67. doi: 10.3727/105221618X15337408678723. Epub 2018 Aug 9.

5.

A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development.

Boege Y, Malehmir M, Healy ME, Bettermann K, Lorentzen A, Vucur M, Ahuja AK, Böhm F, Mertens JC, Shimizu Y, Frick L, Remouchamps C, Mutreja K, Kähne T, Sundaravinayagam D, Wolf MJ, Rehrauer H, Koppe C, Speicher T, Padrissa-Altés S, Maire R, Schattenberg JM, Jeong JS, Liu L, Zwirner S, Boger R, Hüser N, Davis RJ, Müllhaupt B, Moch H, Schulze-Bergkamen H, Clavien PA, Werner S, Borsig L, Luther SA, Jost PJ, Weinlich R, Unger K, Behrens A, Hillert L, Dillon C, Di Virgilio M, Wallach D, Dejardin E, Zender L, Naumann M, Walczak H, Green DR, Lopes M, Lavrik I, Luedde T, Heikenwalder M, Weber A.

Cancer Cell. 2017 Sep 11;32(3):342-359.e10. doi: 10.1016/j.ccell.2017.08.010.

6.

The expression of SIRT3 in primary hepatocellular carcinoma and the mechanism of its tumor suppressing effects.

Liu Y, Liu YL, Cheng W, Yin XM, Jiang B.

Eur Rev Med Pharmacol Sci. 2017 Mar;21(5):978-998.

7.

Molecular mechanisms of apoptosis in hepatocellular carcinoma cells induced by ethanol extracts of Solanum lyratum Thumb through the mitochondrial pathway.

Mo XQ, Wei HY, Huang GR, Xu LY, Chen YL, Qi J, Xian W, Qin YC, Wei LD, Zhao LJ, Huang YQ, Xing W, Pu HQ, Wei PY, Li CG, Liang QC.

World J Gastroenterol. 2017 Feb 14;23(6):1010-1017. doi: 10.3748/wjg.v23.i6.1010.

8.

Heterogeneous dimer peptide-conjugated polylysine dendrimer-Fe3O4 composite as a novel nanoscale molecular probe for early diagnosis and therapy in hepatocellular carcinoma.

Shen JM, Li XX, Fan LL, Zhou X, Han JM, Jia MK, Wu LF, Zhang XX, Chen J.

Int J Nanomedicine. 2017 Feb 10;12:1183-1200. doi: 10.2147/IJN.S126887. eCollection 2017.

9.

Melatonin Activates Endoplasmic Reticulum Stress and Apoptosis in Rats with Diethylnitrosamine-Induced Hepatocarcinogenesis.

Moreira AJ, Ordoñez R, Cerski CT, Picada JN, García-Palomo A, Marroni NP, Mauriz JL, González-Gallego J.

PLoS One. 2015 Dec 11;10(12):e0144517. doi: 10.1371/journal.pone.0144517. eCollection 2015.

10.

Anticancer agent icaritin induces apoptosis through caspase-dependent pathways in human hepatocellular carcinoma cells.

Sun L, Peng Q, Qu L, Gong L, Si J.

Mol Med Rep. 2015 Apr;11(4):3094-100. doi: 10.3892/mmr.2014.3007. Epub 2014 Nov 26.

PMID:
25434584
11.

Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2.

Lee YH, Seo D, Choi KJ, Andersen JB, Won MA, Kitade M, Gómez-Quiroz LE, Judge AD, Marquardt JU, Raggi C, Conner EA, MacLachlan I, Factor VM, Thorgeirsson SS.

Cancer Res. 2014 Sep 1;74(17):4752-61. doi: 10.1158/0008-5472.CAN-13-3531. Epub 2014 Jun 23.

12.

Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.

Fujii Y, Segawa R, Kimura M, Wang L, Ishii Y, Yamamoto R, Morita R, Mitsumori K, Shibutani M.

Chem Biol Interact. 2013 Sep 25;205(2):108-18. doi: 10.1016/j.cbi.2013.06.017. Epub 2013 Jul 2.

PMID:
23830814
13.

Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.

Frau M, Feo F, Pascale RM.

J Hepatol. 2013 Oct;59(4):830-41. doi: 10.1016/j.jhep.2013.04.031. Epub 2013 May 7. Review.

14.

In vitro and in vivo comparison of 18F and 123I-labeled ML10 with 68Ga-Cys2-AnxA5 for molecular imaging of apoptosis.

Bauwens M, De Saint-Hubert M, Cleynhens J, Vandeputte C, Li J, Devos E.

Q J Nucl Med Mol Imaging. 2013 Jun;57(2):187-200. Epub 2013 Feb 6.

PMID:
23389693
15.

Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model.

Lin HC, Chen YF, Hsu WH, Yang CW, Kao CH, Tsai TF.

Cancer Prev Res (Phila). 2012 Jul;5(7):952-62. doi: 10.1158/1940-6207.CAPR-12-0001. Epub 2012 Jun 1.

16.

Hepatitis B virus alters the antioxidant system in transgenic mice and sensitizes hepatocytes to Fas signaling.

Wang Q, Na B, Ou JH, Pulliam L, Yen TS.

PLoS One. 2012;7(5):e36818. doi: 10.1371/journal.pone.0036818. Epub 2012 May 11.

17.

The role of TNF and Fas dependent signaling in animal models of inflammatory liver injury and liver cancer.

Liedtke C, Trautwein C.

Eur J Cell Biol. 2012 Jun-Jul;91(6-7):582-9. doi: 10.1016/j.ejcb.2011.10.001. Epub 2011 Dec 6. Review.

PMID:
22153863
18.

A new membrane re-anchored protein originating from GPC3 against hepatoma cells HepG2.

Yang D, Yang J, Lu F, Li C, Yang J, Liang J.

Mol Med Rep. 2011 Nov-Dec;4(6):1067-73. doi: 10.3892/mmr.2011.536. Epub 2011 Jul 19.

PMID:
21904776
19.

Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury.

Liedtke C, Bangen JM, Freimuth J, Beraza N, Lambertz D, Cubero FJ, Hatting M, Karlmark KR, Streetz KL, Krombach GA, Tacke F, Gassler N, Riethmacher D, Trautwein C.

Gastroenterology. 2011 Dec;141(6):2176-87. doi: 10.1053/j.gastro.2011.08.037. Epub 2011 Aug 28.

PMID:
21878202
20.

Altered composition of fatty acids exacerbates hepatotumorigenesis during activation of the phosphatidylinositol 3-kinase pathway.

Kudo Y, Tanaka Y, Tateishi K, Yamamoto K, Yamamoto S, Mohri D, Isomura Y, Seto M, Nakagawa H, Asaoka Y, Tada M, Ohta M, Ijichi H, Hirata Y, Otsuka M, Ikenoue T, Maeda S, Shiina S, Yoshida H, Nakajima O, Kanai F, Omata M, Koike K.

J Hepatol. 2011 Dec;55(6):1400-8. doi: 10.1016/j.jhep.2011.03.025. Epub 2011 May 19.

PMID:
21703185

Supplemental Content

Loading ...
Support Center